BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37340108)

  • 1. Adjuvant Chemotherapy Is Associated with Improved Survival for Stage III Colon Cancer When Initiated Beyond 8 Weeks.
    Ahmed FA; Wu VS; Kakish H; Rothermel L; Stein SL; Steinhagen E; Hoehn R
    J Gastrointest Surg; 2023 Sep; 27(9):1913-1924. PubMed ID: 37340108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.
    Peixoto RD; Kumar A; Speers C; Renouf D; Kennecke HF; Lim HJ; Cheung WY; Melosky B; Gill S
    Clin Colorectal Cancer; 2015 Mar; 14(1):25-30. PubMed ID: 25465343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
    Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
    J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer.
    Bos AC; van Erning FN; van Gestel YR; Creemers GJ; Punt CJ; van Oijen MG; Lemmens VE
    Eur J Cancer; 2015 Nov; 51(17):2553-61. PubMed ID: 26360411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study.
    Gao P; Huang XZ; Song YX; Sun JX; Chen XW; Sun Y; Jiang YM; Wang ZN
    BMC Cancer; 2018 Mar; 18(1):234. PubMed ID: 29490625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
    Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
    Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimally invasive surgery for stage III colon adenocarcinoma is associated with less delay to initiation of adjuvant systemic therapy and improved survival.
    Lee L; Wong-Chong N; Kelly JJ; Nassif GJ; Albert MR; Monson JRT
    Surg Endosc; 2019 Feb; 33(2):460-470. PubMed ID: 29967992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the Optimal Timing for Initiation of Adjuvant Chemotherapy After Resection for Stage II and III Colon Cancer.
    Sun Z; Adam MA; Kim J; Nussbaum DP; Benrashid E; Mantyh CR; Migaly J
    Dis Colon Rectum; 2016 Feb; 59(2):87-93. PubMed ID: 26734965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delay in Adjuvant Chemotherapy and Survival Advantage in Stage III Colon Cancer.
    Turner MC; Farrow NE; Rhodin KE; Sun Z; Adam MA; Mantyh CR; Migaly J
    J Am Coll Surg; 2018 Apr; 226(4):670-678. PubMed ID: 29378259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system.
    Chen Y; Shankaran V; Hahn EE; Haupt EC; Bansal A
    J Manag Care Spec Pharm; 2023 Jun; 29(6):635-646. PubMed ID: 37276035
    [No Abstract]   [Full Text] [Related]  

  • 11. Patterns of Adjuvant Chemotherapy Use and Association With Survival in Adults 80 Years and Older With Pancreatic Adenocarcinoma.
    Mehtsun WT; McCleary NJ; Maduekwe UN; Wolpin BM; Schrag D; Wang J
    JAMA Oncol; 2022 Jan; 8(1):88-95. PubMed ID: 34854874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complicated postoperative recovery increases omission, delay and discontinuation of adjuvant chemotherapy in patients with Stage III colon cancer.
    van der Geest LG; Portielje JE; Wouters MW; Weijl NI; Tanis BC; Tollenaar RA; Struikmans H; Nortier JW;
    Colorectal Dis; 2013; 15(10):e582-91. PubMed ID: 23679338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Associated With Adjuvant Chemotherapy Noncompliance and Survival in Older Adults With Stage III Colon Cancer.
    Simon HL; Reif de Paula T; Spigel ZA; Keller DS
    Dis Colon Rectum; 2023 Sep; 66(9):1254-1262. PubMed ID: 36574320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better Late than Never? Adherence to Adjuvant Therapy Guidelines for Stage III Colon Cancer in an Underserved Region.
    Guerrero W; Wise A; Lim G; Dong L; Wan J; Deneve J; Glazer E; Dickson P; Daugherty RS; Fleming M; Shibata D
    J Gastrointest Surg; 2018 Jan; 22(1):138-145. PubMed ID: 29119529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A national evaluation of the use and survival impact of adjuvant chemotherapy in Stage II colon cancer from the national cancer database.
    Reif de Paula T; Gorroochurn P; Simon HL; Haas EM; Keller DS
    Colorectal Dis; 2022 Jan; 24(1):40-49. PubMed ID: 34605166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
    Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW;
    J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A; Casadaban L; Maker AV
    J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Population-Based Cohort Study of Venous Thromboembolism Rates Following Surgery and During Adjuvant Chemotherapy in Patients With Colon Cancer.
    Patel SV; Zhang L; Wei XS; Merchant SJ; Nanji S; James PD; Booth CM
    Dis Colon Rectum; 2020 Mar; 63(3):336-345. PubMed ID: 32045399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adequacy of the National Quality Forum's Colon Cancer Adjuvant Chemotherapy Quality Metric: Is 4 Months Soon Enough?
    Massarweh NN; Haynes AB; Chiang YJ; Chang GJ; You YN; Feig BW; Cormier JN
    Ann Surg; 2015 Aug; 262(2):312-20. PubMed ID: 25185467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.